A nasal spray of the anti-opioid drug naloxone, developed by Daniel Wermeling, has FDA fast-track designation.
Thorson published findings on a new antibiotic derived from a soil bacterium from a KY coal fire.
Phoebe Glazer is making light-activated, ruthenium-based molecules that will kill only cancerous cells.
